Keystone Clinical Studies LLC, dba Flourish Research — Plymouth Meeting, Pennsylvania

Keystone Clinical Studies LLC, dba Flourish Research is a clinical research site located in Plymouth Meeting, Pennsylvania, United States 19462.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Keystone Clinical Studies LLC, dba Flourish Research has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Venous Thromboembolism (VTE).

Sponsors: Regeneron Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Plymouth Meeting

Browse all research sites in Pennsylvania · View every site in Plymouth Meeting

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Keystone Clinical Studies LLC, dba Flourish Research?

Keystone Clinical Studies LLC, dba Flourish Research has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Keystone Clinical Studies LLC, dba Flourish Research conducted?

Keystone Clinical Studies LLC, dba Flourish Research has 1 clinical trials on record, with 1 currently active. Their work covers Venous Thromboembolism (VTE).

Is Keystone Clinical Studies LLC, dba Flourish Research accredited by Crixeo Clinical Trials?

Keystone Clinical Studies LLC, dba Flourish Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Keystone Clinical Studies LLC, dba Flourish Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.